Atlas Trials

The Efficacy of CAPCT in Patients With PTCL

Clinical trial NCT07746245 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07746245
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Peripheral T-Cell Lymphoma
Start date
2026-08-01
Primary completion
2028-07-31
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.